87
Views
8
CrossRef citations to date
0
Altmetric
Commentary

Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: A randomized study caveat

Pages 1667-1669 | Published online: 01 Jul 2009

References

  • Specht L. 2-[18F]Fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol 2007; 17: 190–197
  • Allen-Auerbach M, Quon A, Weber W A, Obrzut S, Crawford T, Silverman D H, et al. Comparison between 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 2004; 6: 411–416
  • Schaefer N G, Hany T F, Taverna C, Seifert B, Stumpe K D, von Schulthess G K, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging – do we need contrast-enhanced CT?. Radiology 2004; 232: 823–829
  • Hoppe R T, Adjvani R H, Bierman P J, Bloomfield C D, Buadi F, Djulgegovic B, et al. NCCN physician guidelines: Hodgkin Disease 2007 v.1, Available at: www.nccn.org
  • Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
  • Cheson B D, Pfistner B, Juweid M E, Gascoyne R D, Specht L, Horning S J, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579–586
  • Hutchings M, Loft A, Hansen M, Pedersen L M, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006; 107: 52–59
  • Coleman M, Kostakoglu L. Early 18F-labeled fluoro-2-deoxy-d-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?. Cancer 2006; 107: 1425–1428
  • Zinzani P L, Tani M, Fanti S, Alinari L, Musuraca G, Marchi E, et al. Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Ann Oncol 2006; 17: 1296–1300
  • Yahalom J. Favorable early-stage Hodgkin lymphoma. J Natl Compr Cancer Network 2006; 4: 233–240
  • Picardi M, De Renzo A, Pane F, et al. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Leuk Lymphoma 2007; 48: 1721–1727
  • Yahalom J. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma. J Clin Oncol 2006; 24: 544–548

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.